Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   A Placebo-Controlled, Double-Blind, Randomized, Multi-Center Study to Assess the Effects of Multaq® 400 mg BID for 12 Weeks on Atrial Fibrillation Burden in Subjects with Permanent Pacemakers
Description of Research   The purpose of the study is the evaluate what effects the study drug Multaq (dronedarone) has on the total amount of time artrial fibrillation is experienced by the patient.
Study Number   HSR-10-1119
Inclusion/Notes   For patients who have been diagnosed with atrial fibrillation who have a permanent pacemaker and whose treatment involves the study drug Multaq (dronedarone).
Principal Investigator   James Kappler, MD
Contact Name   Gail Brandt, RN
Phone   (734) 712-8386
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456